Astra Zeneca
Recent News About Astra Zeneca
-
Consumer regulatory attorney debunks shareholder lawsuit against vaccine maker AstraZeneca
Investors who acquired AstraZeneca stock last year have filed a class-action lawsuit, alleging that the COVID-19 vaccine manufacturer made false statements to the market but a consumer regulatory attorney asserts that the litigation is unlikely to succeed